Kanchan Relwani
About Kanchan Relwani
Kanchan Relwani is the Senior Vice President, Head of Medical Affairs at Alkermes, with over a decade of experience in medical affairs and leadership roles in the pharmaceutical industry.
Current Role at Alkermes
Kanchan Relwani serves as the Senior Vice President and Head of Medical Affairs at Alkermes. In this capacity, she oversees the medical affairs strategies and operations, contributing to the development and deployment of medical communications and support for Alkermes’ pharmaceutical products.
Previous Roles at Alkermes
Prior to her current role, Kanchan Relwani held several leadership positions at Alkermes. She was the Vice President, Head of Medical Affairs from 2018 to 2020 and the Vice President, Medical Strategy, Medical Affairs from 2017 to 2018. In these roles, she was responsible for spearheading medical strategy initiatives and overseeing medical communication efforts.
Experience at Vertex Pharmaceuticals
Kanchan Relwani has significant experience at Vertex Pharmaceuticals, where she served in multiple senior roles. She was the Senior Director, Head of North America Medical Affairs from 2014 to 2016, Senior Director, Global Medical Affairs from 2013 to 2014, and Director, Medical Affairs from 2012 to 2013. In these capacities, she led medical affairs strategies both regionally and globally.
Educational Background
Kanchan Relwani has an extensive educational background. She earned her bachelor's degree in Medicine and Surgery from Pune University in India and holds a Diploma in Ophthalmic Medicine and Surgery from the National Institute of Ophthalmology in India. She also completed a Postdoctoral Fellowship at Harvard Medical School, focusing on the genetics of glaucoma.
Early Career and Research
Earlier in her career, Kanchan Relwani conducted significant postdoctoral research, specifically at the Massachusetts Eye and Ear Infirmary (2005-2007) where she focused on the genetics of glaucoma. Additionally, she worked as a Senior Medical Writer/Reviewer at Custom Learning Designs from 2007 to 2008, contributing to the development and review of medical content.